Amneal Pharmaceuticals, Inc.
AMRX
$17.25
$0.201.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.38% | 77.49% | 1,380.62% | -89.43% | 83.82% |
| Total Depreciation and Amortization | 10.67% | -12.26% | -8.96% | -10.05% | -0.08% |
| Total Amortization of Deferred Charges | 4.47% | 4.71% | -26.14% | -26.84% | 0.94% |
| Total Other Non-Cash Items | 12.47% | -1.07% | -49.32% | 264.87% | -14.73% |
| Change in Net Operating Assets | -0.75% | -1,446.64% | 75.78% | -44.52% | 67.00% |
| Cash from Operations | 20.56% | -120.52% | 10.02% | 41.32% | 1,031.47% |
| Capital Expenditure | -228.95% | 67.89% | -186.84% | 43.21% | -87.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | 63.17% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -882.80% | -161.67% | 59.54% | -723.78% | 78.57% |
| Cash from Investing | -465.37% | 52.24% | -102.34% | 15.38% | -49.16% |
| Total Debt Issued | -26.40% | 16,904.15% | -99.97% | -- | -100.00% |
| Total Debt Repaid | 95.61% | -2,199.84% | 99.76% | -16,328.53% | 93.40% |
| Issuance of Common Stock | 10.53% | -93.13% | -15.31% | -4.67% | 892.75% |
| Repurchase of Common Stock | 99.60% | -13,702.18% | -148.84% | 31.75% | 99.13% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -51.28% | -81.74% | 94.23% | -226.99% | -39,069.12% |
| Cash from Financing | 234.38% | -483.55% | -117.02% | 242.59% | -6.44% |
| Foreign Exchange rate Adjustments | 83.97% | -389.47% | 69.88% | -126.06% | 34.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.30% | -245.62% | -51.83% | 912.80% | 130.54% |